GLUE
Price
$4.95
Change
-$0.11 (-2.17%)
Updated
Apr 28 closing price
Capitalization
304.47M
9 days until earnings call
RPTX
Price
$1.36
Change
+$0.11 (+8.80%)
Updated
Apr 28 closing price
Capitalization
57.81M
14 days until earnings call
Ad is loading...

GLUE vs RPTX

Header iconGLUE vs RPTX Comparison
Open Charts GLUE vs RPTXBanner chart's image
Monte Rosa Therapeutics
Price$4.95
Change-$0.11 (-2.17%)
Volume$283.9K
Capitalization304.47M
Repare Therapeutics
Price$1.36
Change+$0.11 (+8.80%)
Volume$276.02K
Capitalization57.81M
GLUE vs RPTX Comparison Chart
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLUE vs. RPTX commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Buy and RPTX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (GLUE: $4.95 vs. RPTX: $1.36)
Brand notoriety: GLUE and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 35% vs. RPTX: 82%
Market capitalization -- GLUE: $304.47M vs. RPTX: $57.81M
GLUE [@Biotechnology] is valued at $304.47M. RPTX’s [@Biotechnology] market capitalization is $57.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than GLUE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 4 TA indicator(s) are bullish while RPTX’s TA Score has 5 bullish TA indicator(s).

  • GLUE’s TA Score: 4 bullish, 5 bearish.
  • RPTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RPTX is a better buy in the short-term than GLUE.

Price Growth

GLUE (@Biotechnology) experienced а +10.99% price change this week, while RPTX (@Biotechnology) price change was +13.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.10%. For the same industry, the average monthly price growth was -2.09%, and the average quarterly price growth was -11.07%.

Reported Earning Dates

GLUE is expected to report earnings on Aug 07, 2025.

RPTX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($304M) has a higher market cap than RPTX($57.8M). RPTX YTD gains are higher at: 3.817 vs. GLUE (-28.674). GLUE has higher annual earnings (EBITDA): -72.99M vs. RPTX (-90.22M). GLUE has more cash in the bank: 372M vs. RPTX (153M). RPTX has less debt than GLUE: RPTX (1.93M) vs GLUE (42.7M). GLUE has higher revenues than RPTX: GLUE (75.6M) vs RPTX (53.5M).
GLUERPTXGLUE / RPTX
Capitalization304M57.8M526%
EBITDA-72.99M-90.22M81%
Gain YTD-28.6743.817-751%
P/E RatioN/AN/A-
Revenue75.6M53.5M141%
Total Cash372M153M243%
Total Debt42.7M1.93M2,209%
TECHNICAL ANALYSIS
Technical Analysis
GLUERPTX
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
86%
MACD
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 5 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 15 days ago
88%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 20 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 5 days ago
88%
View a ticker or compare two or three
Ad is loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with ATXS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-2.17%
ATXS - GLUE
42%
Loosely correlated
-4.06%
CRSP - GLUE
40%
Loosely correlated
-1.02%
IMNM - GLUE
40%
Loosely correlated
+2.14%
KYMR - GLUE
39%
Loosely correlated
+1.05%
FATE - GLUE
39%
Loosely correlated
-2.34%
More

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+8.80%
INO - RPTX
57%
Loosely correlated
+1.07%
BCYC - RPTX
47%
Loosely correlated
-0.24%
CADL - RPTX
38%
Loosely correlated
-0.20%
EDIT - RPTX
31%
Poorly correlated
+2.60%
PALI - RPTX
31%
Poorly correlated
+7.82%
More